Literature DB >> 23683483

Biologic agents and oral diseases -- an update on clinical applications.

Eleni A Georgakopoulou1, Dimitrios Andreadis, Efthymios Arvanitidis, Panagiota Loumou.   

Abstract

Biologic agents are targeted immune modulating agents that have been widely used in the treatment of inflammatory and neoplastic conditions with favorable results. The purpose of this review is to provide an update on the biologic agents that have been used in the treatment of diseases that affect the oral mucosa. Identification of relevant data, case reports and case series was performed using the PubMed-MEDLINE database and electronic databases of accredited organizations such as the European Medical Agency, US Food and Drug Administration, and clinicaltrials.gov (USA). According to the literature, the use of biologic agents in patients with oral diseases is limited mainly to patients suffering from refractory forms of immune-mediated diseases of the oral cavity. Biologic agents were used in all cases as off-label indications. Patient's response varied, but in general biologic agents could be considered as a therapeutic option in patients with no other alternative. A point requiring extra precaution is their safety profile because severe life threatening infections are among their side effects. Another aspect that limits their broader use is their high economic cost. We aimed to provide a practical update for the clinicians who deal with oral diseases, covering as many aspects as possible of the applications of biologic agents in oral diseases reported to date.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23683483

Source DB:  PubMed          Journal:  Acta Dermatovenerol Croat        ISSN: 1330-027X            Impact factor:   1.256


  5 in total

Review 1.  Biological agents: what they are, how they affect oral health and how they can modulate oral healthcare.

Authors:  E Georgakopoulou; C Scully
Journal:  Br Dent J       Date:  2015-07       Impact factor: 1.626

Review 2.  Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check.

Authors:  Shesha Prasad Ranganath; Anuradha Pai
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  World Workshop on Oral Medicine VII: Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review.

Authors:  Luiz A Gueiros; Katherine France; Rachael Posey; Jacqueline W Mays; Barbara Carey; Thomas P Sollecito; Jane Setterfield; Sook Bin Woo; Donna Culton; Aimee S Payne; Giovanni Lodi; Martin S Greenberg; Scott De Rossi
Journal:  Oral Dis       Date:  2019-06       Impact factor: 3.511

4.  Oral non-Hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate.

Authors:  Eleni A Georgakopoulou; Marina D Achtari; Kostas Evangelou; Christos Kittas
Journal:  J Clin Exp Dent       Date:  2015-02-01

5.  Highly suspected primary intraocular lymphoma in a patient with rheumatoid arthritis treated with etanercept: a case report.

Authors:  Woo Keun Song; Ah Ran Cho; Young Hee Yoon
Journal:  BMC Ophthalmol       Date:  2018-06-28       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.